Panacea Biotec Ltd. appointed Mr. Rajesh Jain as an Independent Director for its subsidiary Panacea Biotec Pharma Limited for a term of 5 years and plans to provide a corporate guarantee for up to $20 million (approximately ₹168.16 crore) to facilitate the parent companys external commercial borrowings for vaccine manufacturing capacity expansion and loan refinancing.